PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE Trial

Author:

Norgren Lars,Weiss Norbert,Nikol Sigrid,Hinchliffe Robert J.,Lantis John C.,Patel Manesh R.,Reinecke Holger,Ofir Racheli,Rosen Yael,Peres Dan,Aberman Zami

Funder

AnGes

AstraZeneca

Bayer

CESCA

Mitsubishi

Pluristem

N Weiss

Amgen

Bard

Fresenius

Merck

Pfizer

Terumo

Jansen

AstraZenca

BMS

MedUpdate

NephroUpdate

European Union's Horizon 2020 Research and Innovation Programme

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Surgery

Reference29 articles.

1. Inter-society consensus for the management of peripheral arterial disease (TASC II);Norgren;Eur J Vasc Endovasc Surg,2007

2. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis;Fowkes;Lancet,2013

3. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American college of cardiology/American Heart association task force on clinical practice guidelines;Gerhard-Herman;Circulation,2017

4. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS);Aboyans;Eur J Vasc Endovasc Surg,2017

5. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomized placebo-controlled trial of gene therapy in critical limb ischemia;Belch;Lancet,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3